Trends in Pediatric Oncology and HCT ICU Admissions
Author Information
Author(s): Kyle B. Lenz, R. Scott Watson, Jennifer J. Wilkes, Matthew R. Keller, Mary E. Hartman, Elizabeth Y. Killien
Primary Institution: Seattle Children’s Hospital, University of Washington
Hypothesis
ICU admission frequency, prevalence of chronic comorbid conditions, and organ dysfunction have all increased among pediatric oncology and HCT patients over the past two decades.
Conclusion
Pediatric oncology and HCT patients are increasingly medically complex, with rising prevalence of chronic comorbidities and organ failure, but mortality has improved.
Supporting Evidence
- ICU admission prevalence rose from 13.6% in 2001 to 14.4% in 2019 for oncology admissions.
- The prevalence of chronic non-oncologic comorbidities among ICU patients rose from 44.3% to 69.1% for oncology patients.
- Mortality decreased for ICU patients with acute myeloid leukemia from 14.6% to 8.5%.
Takeaway
Kids with cancer or who had a stem cell transplant often need special hospital care, and while they are getting sicker, fewer of them are dying.
Methodology
Retrospective cohort study using Healthcare Cost and Utilization Project’s State Inpatient Databases from 21 U.S. states from 2001-2019.
Potential Biases
Potential bias in coding practices and exclusion of patients over 17 years old.
Limitations
Variability in included states each year, counts refer to admissions not patients, and reliance on ICD codes may affect diagnosis accuracy.
Participant Demographics
Children aged 0-17 years with oncologic or HCT diagnoses.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 1.46-1.66
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website